Eli Mrkusich works for Illumina, the world’s leading genomics (DNA information) company. When Illumina entered the DNA sequencing market a genome (compete DNA sequence) cost $10 million dollars in 2014 Illumina launched the $1,000 genome. Illumina’s technology powers 23andMe and AncestryDNA. Illumina’s mission to unlock the power of the genome to improve human health.
Eli joined Illumina in 2015 and is a Senior Applied Genomics Segment Manager for Asia Pacific and Japan (APJ) and is based on the Mornington Peninsula. Eli is responsible for market development and outbound marketing activities for the Applied Genomics business across APJ. Eli completed his PhD in neuroscience and molecular biology in 2004 and had six years post-doctoral experience at the University of Melbourne. Eli worked for Bio-Rad for five years in an application support role, most recently as a Global Digital Applications Specialist for Bio-Rad supporting Droplet Digital PCR, based out of Pleasanton, California.